TB-500 10mg COA: Why Certificate of Analysis Matters

A TB-500 10mg COA, or Certificate of Analysis, is an analytical document used to identify and characterize a particular batch of research material. For laboratories evaluating TB-500 research peptide material, a COA can provide important information such as lot number, testing date, analytical method, purity result, identity testing, physical appearance, and other applicable quality-control measurements.

For research buyers, the most important point is that a COA should be batch-specific. A certificate belonging to one lot should not automatically be treated as evidence for another lot.

Current publicly available TB-500 10mg certificates illustrate why batch-level documentation matters. For example, published certificates from several research suppliers report HPLC purity results in different ranges and use different analytical approaches, including HPLC and LC-MS. These are examples of individual batches and should not be interpreted as a universal TB-500 purity specification.

For Peptides Grey House, a strong TB-500 10mg COA page should therefore emphasize traceability, analytical transparency, identity confirmation, purity testing, and documentation rather than making unsupported claims about a material’s suitability for any particular application.

What Is a TB-500 10mg COA?

A Certificate of Analysis is a laboratory document associated with a specific material or production lot.

For a TB-500 10mg research product, the COA may include:

• Product name
• Lot or batch number
• Report number
• Testing laboratory
• Analysis date
• Sample description
• Net peptide content
• HPLC purity
• Identity testing
• LC-MS or mass-spectrometry information
• Appearance
• Moisture or water content, where tested
• Residual solvent testing, where applicable
• Endotoxin or microbiological testing, where applicable
• Specification and result
• Pass/fail determination
• Authorized laboratory personnel or approval information

The exact contents vary between laboratories and certificates.

A useful COA is not simply a document containing a large purity percentage. Researchers should be able to connect the document to the specific lot being evaluated.

TB-500 10mg Research Peptide: Understanding the Material

TB-500 is commonly used as the name for the synthetic peptide sequence N-acetyl-LKKTETQ.

PubChem identifies TB-500 with the molecular formula C38H68N10O14, molecular weight approximately 889.0 g/mol, and sequence LKKTETQ. Its condensed structure is listed as Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH.

This distinction is important because online product page

s sometimes incorrectly describe TB-500 as the entire 43-amino-acid thymosin beta-4 molecule.

For SEO content and technical product documentation, Peptides Grey House should avoid treating TB-500 and full-length thymosin beta-4 as interchangeable substances.

A clear technical description is:

TB-500 is an N-acetylated heptapeptide represented by the sequence Ac-LKKTETQ.

This provides researchers with a more precise starting point when comparing COAs, analytical reports, reference materials, and structural information.

TB-500 10mg COA and Molecular Weight

The molecular-weight field on a COA should be interpreted carefully.

For TB-500 free base, PubChem lists:

Property	TB-500
Sequence	LKKTETQ
N-terminal modification	Acetyl
Molecular formula	C38H68N10O14
Molecular weight	889.0 g/mol
Chemical form	Ac-LKKTETQ-OH

However, peptide materials can be supplied in different chemical forms, including salt or counterion-associated forms. PubChem separately identifies a trifluoroacetic-acid-associated TB-500 form, demonstrating why researchers should verify the actual material form rather than assuming that every COA will display the same molecular weight.

Why molecular weight matters on a COA

Mass spectrometry can provide evidence that the material’s observed mass is consistent with the expected molecular identity.

A COA that includes both:

• chromatographic purity information, and
• mass-spectrometric identity information

can provide more useful analytical context than a purity percentage alone.

TB-500 10mg HPLC Testing

High-performance liquid chromatography (HPLC) is one of the most commonly reported analytical techniques used to characterize peptide purity.

HPLC separates components of a sample based on their interactions with a chromatographic system. The resulting chromatogram can show a principal peak associated with the target peptide and additional peaks associated with other detected components.

For a TB-500 10mg COA, researchers may see terminology such as:

• RP-HPLC
• HPLC-UV
• HPLC purity
• Main peak
• Area %
• Retention time
• Related substances
• Chromatographic purity

FDA materials discussing peptide analytical testing describe HPLC and mass spectrometry among techniques used for peptide characterization and impurity evaluation.

What does “99% HPLC purity” mean?

A reported HPLC purity value generally describes the proportion attributed to the principal chromatographic peak under the stated analytical conditions.

It should not automatically be interpreted as:

• 99% total chemical certainty,
• sterility,
• endotoxin-free status,
• clinical-grade material,
• therapeutic efficacy,
• or suitability for human use.

This distinction is essential for responsible research-peptide SEO content.

TB-500 10mg COA and LC-MS Testing

Mass spectrometry can complement HPLC by providing molecular-mass information.

When a laboratory uses LC-MS, chromatography and mass spectrometry are combined. The chromatographic component separates the sample while the mass spectrometer provides molecular-mass information that can help support compound identification.

A strong TB-500 analytical record may therefore contain:

HPLC → chromatographic purity

LC-MS → molecular identity/mass confirmation

The two techniques answer different analytical questions.

For example, one current publicly available TB-500 10mg certificate reports HPLC purity together with mass-spectrometric identification. Another published certificate reports HPLC/UV coupled with mass spectrometry.

This is why researchers should examine the actual analytical method and report, rather than evaluating a product solely from a marketing statement.

How to Read a TB-500 10mg COA

When reviewing a TB-500 10mg certificate, use the following checklist.

1. Check the Product Name

Confirm that the certificate identifies the material as TB-500 or the specific nomenclature used by the testing laboratory.

2. Check the Lot Number

The lot number is one of the most important fields.

The COA should correspond to the batch or lot number printed on the product documentation or packaging.

3. Check the Testing Date

A certificate should identify when the sample was analyzed.

This helps researchers understand the relationship between the certificate and the material being evaluated.

4. Check the Testing Laboratory

Look for the name of the analytical laboratory.

Third-party testing can provide additional separation between product supply and analytical evaluation when the laboratory is genuinely independent.

5. Check HPLC Purity

Look for:

• HPLC method
• detector information
• reported purity
• chromatogram, when available
• specification
• impurity profile, when available

6. Check Identity Testing

Look for an identity method such as:

• LC-MS
• mass spectrometry
• other validated analytical identification techniques

A purity result alone does not establish molecular identity.

7. Check Net Content

For a product described as TB-500 10mg, the analytical document may report a measured peptide content or sample amount.

Do not automatically equate the nominal product label with an independently measured active content result.

8. Check the Report Number

A report or certificate number helps establish document traceability.

9. Check the Result and Specification

A useful COA should distinguish between:

Specification: what the laboratory or supplier says the material is expected to meet.

Result: what was actually measured.

That distinction makes analytical documentation easier to interpret.

TB-500 Purity: What Current COAs Show

Publicly accessible TB-500 certificates demonstrate that reported purity can vary from batch to batch.

For example, one current certificate archive reports TB-500 10mg HPLC results ranging from 99.17% to 99.86% across five third-party test results issued between December 2025 and September 2026. The same archive notes that mass-spectrometric identity was confirmed on four of those certificates.

Other publicly available 10mg certificates report values such as 99.21%, 98.93%, 98.67%, 99.30%, and 99.83%, depending on the individual supplier, lot, laboratory, and analytical record.

These figures should not be combined into a universal TB-500 purity benchmark. They illustrate an important research-documentation principle:

The relevant purity result is the result for the specific batch under the stated analytical method.

A percentage without a lot number, method, testing laboratory, and report is much less informative.

Why Batch-Specific TB-500 COA Verification Matters

Batch traceability is central to analytical transparency.

Suppose a researcher sees a webpage advertising:

TB-500 — 99%+ purity

That statement does not answer several important questions:

• Which batch?
• Which laboratory?
• Which analytical method?
• What date was it tested?
• Was identity confirmed?
• Is the certificate publicly available?
• Does the lot number match the material?
• What specification was applied?

A stronger documentation system connects the product to a specific analytical record.

Some current TB-500 certificate libraries explicitly instruct users to match the lot number on the material with the lot number on the certificate.

That approach provides a useful model for transparent research-material documentation.

What a High-Quality TB-500 COA Should Ideally Include

For a research-focused product page, the following COA elements provide useful information:

Identity

Confirms that the tested material is consistent with the stated compound.

HPLC Purity

Provides chromatographic information about the main component and detected impurities.

Mass Spectrometry

Provides molecular-mass evidence supporting identity.

Lot Number

Connects the certificate to a specific production batch.

Testing Laboratory

Identifies who performed the analysis.

Testing Date

Shows when the sample was evaluated.

Net Peptide Content

Provides information about measured material content where applicable.

Appearance

Documents the physical appearance of the tested sample.

Additional Quality Tests

Depending on the intended laboratory application, documentation may include moisture, residual solvents, endotoxins, microbiological testing, or other parameters.

The exact testing panel should be evaluated according to the intended research application.

TB-500 COA vs. Product Description

A product description and a COA serve different purposes.

A product page may tell researchers:

• product name
• nominal amount
• general research-use statement
• chemical information
• storage information
• packaging details

A COA provides analytical documentation associated with a particular lot.

Therefore, a strong Peptides Grey House product page can use both:

Product page → explains the research material

COA → documents the tested batch

This distinction can also improve SEO because it allows separate content clusters around:

• TB-500 10mg
• TB-500 10mg COA
• TB-500 purity
• TB-500 HPLC
• TB-500 LC-MS
• TB-500 certificate of analysis
• TB-500 batch testing
• TB-500 research peptide

TB-500 Analytical Testing and Research Documentation

Analytical testing is particularly important for synthetic peptides because closely related peptide impurities, degradation products, salts, residual manufacturing components, and other variables may influence the analytical profile.

FDA materials describe the use of chromatographic and mass-spectrometric approaches in peptide characterization and impurity analysis.

For research-material documentation, this means that a comprehensive analytical package can be more useful than a single headline purity number.

A researcher evaluating a TB-500 10mg material may therefore want to review:

1. Certificate of Analysis
2. HPLC chromatogram
3. Identity result
4. LC-MS or MS information
5. Lot number
6. Testing date
7. Laboratory identification
8. Additional applicable quality tests

TB-500 10mg COA for U.S. Researchers

For U.S.-targeted SEO, transparency should be prioritized over unsupported quality claims.

A research-peptide page should clearly distinguish laboratory research materials from FDA-approved medicines or commercial therapeutic products.

The presence of a COA does not itself mean that a product is FDA-approved, clinically validated, or appropriate for human administration.

Similarly, a high HPLC percentage does not establish therapeutic efficacy.

The strongest commercial content is therefore documentation-focused:

TB-500 10mg → specific research material

COA → batch documentation

HPLC → chromatographic purity

LC-MS → identity/mass evidence

Research-use statement → appropriate use boundary

This structure communicates useful technical information without making medical claims.

TB-500 10mg COA Quality Checklist

Before evaluating a research-material certificate, researchers can ask:

• Does the COA identify TB-500 clearly?
• Does the lot number match the material?
• Is the testing laboratory identified?
• Is the testing date provided?
• Is HPLC or another appropriate purity method documented?
• Is identity confirmation provided?
• Is mass spectrometry reported?
• Are specifications and actual results separated?
• Is a chromatogram available?
• Are additional tests relevant to the research application documented?
• Is the certificate complete rather than only a marketing summary?
• Is the research-use limitation clearly stated?

This checklist can become a useful on-page resource for the TB-500 10mg COA search query.

Research-Use Statement

TB-500 10mg research material is intended for laboratory research and scientific investigation only. It is not represented as an FDA-approved medication, dietary supplement, or therapeutic product. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition. This page does not provide human or veterinary dosing, administration, injection, or treatment instructions. Researchers should follow appropriate laboratory safety procedures, institutional protocols, supplier documentation, and applicable laws and regulations.

Frequently Asked Questions About TB-500 10mg COA

What is a TB-500 10mg COA?

A TB-500 10mg COA is a Certificate of Analysis documenting analytical results for a particular TB-500 research-material batch. Depending on the laboratory, it may include HPLC purity, identity testing, mass spectrometry, lot information, testing date, and other quality parameters.

What should a TB-500 COA contain?

A useful COA can include the product name, lot number, testing laboratory, testing date, HPLC purity, identity testing, analytical methods, specifications, results, and additional applicable quality-control tests.

Does a COA prove that TB-500 is safe for humans?

No. A COA documents analytical results for a tested material. It does not establish clinical safety, therapeutic efficacy, or authorization for human use.

What does HPLC purity mean for TB-500?

HPLC purity generally describes the proportion attributed to the principal chromatographic peak under the laboratory’s specified analytical conditions. It should not be treated as a guarantee of clinical quality or safety.

Why is LC-MS useful for TB-500 testing?

LC-MS combines chromatographic separation with mass spectrometry. The mass information can provide evidence that the observed material is consistent with the expected molecular identity.

What is the molecular weight of TB-500?

PubChem lists TB-500 free base with a molecular weight of approximately 889.0 g/mol and molecular formula C38H68N10O14.

What is the TB-500 peptide sequence?

PubChem lists the TB-500 sequence as LKKTETQ, with an N-terminal acetyl modification represented as Ac-LKKTETQ-OH.

Does every TB-500 10mg batch have the same purity?

Not necessarily. Published certificates demonstrate that reported analytical results can vary between batches and laboratories. The appropriate result to evaluate is the certificate corresponding to the specific lot being considered.

Why should the lot number match the COA?

Matching the lot number connects the analytical result to the actual batch of material. Without that connection, a certificate may not provide meaningful evidence about the specific material being evaluated.

Is TB-500 the same as full-length thymosin beta-4?

No. TB-500 is commonly identified as the N-acetylated heptapeptide Ac-LKKTETQ, whereas full-length thymosin beta-4 is a substantially longer peptide. Product documentation should distinguish the two rather than treating them as identical materials.